ARTERIAL KETONE-BODY RATIO AS A PREDICTOR OF DONOR LIVER VIABILITY IN HUMAN LIVER-TRANSPLANTATION

被引:37
作者
YAMAOKA, Y
WASHIDA, M
MANAKA, D
GUBERNATIS, G
RINGE, B
OZAKI, N
YAMAGUCHI, T
TAKADA, Y
OLLERICH, M
OZAWA, K
PICHLMAYR, R
机构
[1] HANNOVER MED COLL,DEPT ABDOMINAL & TRANSPLANTAT SURG,HANNOVER,GERMANY
[2] HANNOVER MED COLL,DEPT CLIN CHEM,HANNOVER,GERMANY
关键词
D O I
10.1097/00007890-199301000-00018
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The viability of the donor liver was assessed with regard to early postoperative survival in human liver transplantations from 40 brain-dead donors at Hannover Medical College and 13 living donors at Kyoto University by measuring the arterial ketone body ratio (AKBR). Of 40 grafts harvested from brain-dead patients in Hannover, 35 survived the first week after operation, but 5 developed initial nonfunction of the transplanted graft within the first week. The mean AKBR values were 1.11 +/- 0.11 for grafts that survived and 0.44 +/- 0.10 for grafts that failed (P<0.01). The AKBR values of the 5 initially nonfunctioning cases were all below 0.7. Of 13 grafts harvested from the living donors in Kyoto, all survived the first week. The AKBR values of the donors were all above 1.0, with a mean value of 1.87 +/- 0.23. Among all 53 cases, the survival rate of the grafts with AKBR above 0. 7 was significantly higher than that of the grafts with AKBR below 0.7 (100% vs. 62%, P<0.01). No other donor parameters, including age, dose of dopamine administered, and clinical laboratory findings, were significantly related to differences in graft survival rates. AKBR is a useful index for the evaluation of donor liver viability. Grafts used from donors with AKBR of less than 0.7 have a significantly increased risk of early nonfunction. Grafts from donors with AKBR of greater than 1.0 have, in our experience, always been viable after transplantation.
引用
收藏
页码:92 / 95
页数:4
相关论文
共 14 条
[1]   THE CLINICAL-SIGNIFICANCE OF THE ARTERIAL KETONE-BODY RATIO AS AN EARLY INDICATOR OF GRAFT VIABILITY IN HUMAN LIVER-TRANSPLANTATION [J].
ASONUMA, K ;
TAKAYA, S ;
SELBY, R ;
OKAMOTO, R ;
YAMAMOTO, Y ;
YOKOYAMA, T ;
TODO, S ;
OZAWA, K ;
STARZL, TE .
TRANSPLANTATION, 1991, 51 (01) :164-171
[2]  
GUBERNATIS G, 1989, EUROTRANSPLANT NEWSL, V63, P6
[3]  
MAKOWKA L, 1987, TRANSPLANT P, V19, P2379
[4]  
OZAWA K, 1983, ARCH SURG-CHICAGO, V118, P1245
[5]  
OZAWA K, 1983, MOL CELLULAR ASPECTS, P39
[6]  
PAULSEN AW, 1989, TRANSPLANT P, V21, P2337
[7]  
PICHLMAYR R, 1987, TRANSPLANT P, V19, P103
[8]   AIMS AND PRACTICAL APPLICATION OF A MULTI ORGAN PROCUREMENT PROTOCOL [J].
RINGE, B ;
NEUHAUS, P ;
PICHLMAYR, R ;
HEIGEL, B .
LANGENBECKS ARCHIV FUR CHIRURGIE, 1985, 365 (01) :47-55
[9]  
SHAW BW, 1989, TRANSPLANT P, V21, P2407
[10]   SIGNIFICANCE OF ARTERIAL KETONE-BODY RATIO MEASUREMENT IN HUMAN LIVER-TRANSPLANTATION [J].
TAKI, Y ;
GUBERNATIS, G ;
YAMAOKA, Y ;
OELLERICH, M ;
YAMAMOTO, Y ;
RINGE, B ;
OKAMOTO, R ;
BUNZENDAHL, H ;
BENEKING, M ;
BURDELSKI, M ;
BORNSCHEUER, A ;
OZAWAL, K ;
PICHLMAYR, R .
TRANSPLANTATION, 1990, 49 (03) :535-539